Last reviewed · How we verify

GSK investigational vaccine GSK2340269A — Competitive Intelligence Brief

GSK investigational vaccine GSK2340269A (GSK investigational vaccine GSK2340269A) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vaccine. Area: Immunology/Oncology.

phase 3 Vaccine Immunology/Oncology Biologic Live · refreshed every 30 min

Target snapshot

GSK investigational vaccine GSK2340269A (GSK investigational vaccine GSK2340269A) — GlaxoSmithKline. GSK2340269A is an investigational vaccine designed to stimulate immune responses against specific tumor-associated antigens or infectious disease targets.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
GSK investigational vaccine GSK2340269A TARGET GSK investigational vaccine GSK2340269A GlaxoSmithKline phase 3 Vaccine
Comirnaty BNT162b2 (tozinameran) Pfizer Inc. marketed vaccine SARS-CoV-2 virus 2021-08-23
Prevnar 20 pneumococcal 20-valent conjugate vaccine (PCV20) Pfizer Inc. marketed Pneumococcal conjugate vaccine Streptococcus pneumoniae capsular polysaccharides (20 serotypes) 2021-06-08
Attenuated Hepatitis A Vaccine, H2 Strain Attenuated Hepatitis A Vaccine, H2 Strain Jiangsu Province Centers for Disease Control and Prevention marketed Live attenuated vaccine Hepatitis A virus
Bivalent OPV 2 week interval Bivalent OPV 2 week interval International Centre for Diarrhoeal Disease Research, Bangladesh marketed vaccine
Shingrix shingrix GSK marketed Vaccine Varicella zoster virus
Twinrix for ATN 025 Twinrix for ATN 025 University of North Carolina, Chapel Hill marketed Vaccine Hepatitis A virus and Hepatitis B virus

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Vaccine class)

  1. GlaxoSmithKline · 16 drugs in this class
  2. Sanofi Pasteur, a Sanofi Company · 12 drugs in this class
  3. Pfizer · 6 drugs in this class
  4. International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
  5. Henogen · 3 drugs in this class
  6. Pfizer Inc. · 2 drugs in this class
  7. Sanofi · 2 drugs in this class
  8. Jiangsu Province Centers for Disease Control and Prevention · 2 drugs in this class
  9. BioNTech · 2 drugs in this class
  10. Merck Sharp & Dohme LLC · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). GSK investigational vaccine GSK2340269A — Competitive Intelligence Brief. https://druglandscape.com/ci/gsk-investigational-vaccine-gsk2340269a. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: